#35 Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
The Kentucky Cannabis Industry Association is organizing a free public expo in Lexington to increase access to medical cannabis information and services, featuring licensed practitioners, notary services, and patient support resources in partnership with Kentucky Marijuana Card. This initiative addresses a significant gap in patient education and access to qualified medical cannabis evaluators in Kentucky, where recent legalization has created demand for physician-supervised cannabis care. For clinicians, the expo represents an opportunity to understand the medical cannabis practitioner network developing in their state and how patients are being evaluated and recommended for cannabis therapy. For patients, the event removes barriers to connecting with licensed medical cannabis practitioners and obtaining the necessary documentation for legal access. This type of public engagement event can help normalize cannabis medicine within the healthcare system and improve the continuity of care between primary care physicians and cannabis specialists. Clinicians should be aware that such community initiatives are expanding access to cannabis evaluation and should consider developing referral relationships with legitimate, licensed practitioners participating in these educational events.
💊 Community wellness expos focused on cannabis are becoming increasingly common across states with medical programs, and while these events can improve patient access to information and reduce barriers to physician consultation, clinicians should remain aware that expo environments prioritize marketing and may not always present balanced evidence about efficacy, safety, or appropriate use cases. The involvement of medical cannabis practitioners and patient support services can genuinely help patients navigate certification processes, but the commercial context means attendees may encounter optimistic claims about cannabis benefits that exceed current evidence, particularly for conditions where conventional treatments remain first-line. Healthcare providers should consider these expos as potential touchpoints for patients considering cannabis and be prepared to discuss realistic expectations, potential drug interactions, and the limited evidence base for many marketed indications. Clinicians may find it useful to acknowledge that patients will likely encounter cannabis information and advocates in their communities and proactively engage in shared decision-making conversations about medical cannabis rather than ceding the discussion entirely to commercial or
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
